HDAC9 and diabetes mellitus: We observed that vorinostat decreased eNOS expression in cultured human umbilical vein endothelial cells and in mouse kidneys, which led us to speculate that this partial (but incomplete) reduction in eNOS with HDAC inhibition served to limit eNOS uncoupling and oxidative stress in diabetes [5].